The potential for liquid biopsies in the precision medical treatment of breast cancer

Currently the clinical management of breast cancer relies on relatively few prognostic/predictive clinical markers (estrogen receptor, progesterone receptor, HER2), based on primary tumor biology. Circulating biomarkers, such as circulating tumor DNA (ctDNA) or circulating tumor cells (CTCs) may enh...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Biol Med
Hlavní autoři: Forte, Victoria A., Barrak, Dany K., Elhodaky, Mostafa, Tung, Lily, Snow, Anson, Lang, Julie E.
Médium: Artigo
Jazyk:Inglês
Vydáno: Chinese Anti-Cancer Association 2016
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4850125/
https://ncbi.nlm.nih.gov/pubmed/27144060
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.28092/j.issn.2095-3941.2016.0007
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky